|
Biology and function of SALL4-induced hematopoietic stem cells from cord blood
|
1K01CA163999-01
|
$130,694
|
$130,694
|
Aguila, Jerell
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144-07130
|
$1,066,163
|
$106,616
|
Alter, Blanche
|
DCEG (NCI)
|
|
Host-tumor cell interaction in myeloma: therapeutic applications
|
5P01CA078378-12
|
$1,984,614
|
$258,000
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
|
Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications
|
5R01CA050947-19
|
$278,781
|
$41,817
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
|
Molecular Studies of Cellular Cytotoxicity
|
ZIA BC 010013
|
$650,805
|
$130,161
|
Anderson, Stephen
|
CCR (NCI)
|
|
THE THERAPY OF AML
|
5P01CA055164-19
|
$2,401,083
|
$480,217
|
ANDREEFF, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Mechanisms of GVHD
|
5P01CA142106-08
|
$1,867,308
|
$1,867,308
|
ANTIN, JOSEPH
|
DANA-FARBER CANCER INSTITUTE
|
|
Collaborative Pathways that Lead to Leukemia
|
ZIA BC 010982
|
$273,950
|
$27,394
|
Aplan, Peter
|
CCR (NCI)
|
|
Pre-clinical Studies of Therapy for Myelodysplastic Syndrome
|
ZIA BC 010983
|
$273,950
|
$273,949
|
Aplan, Peter
|
CCR (NCI)
|
|
Adult Leukemia Research Center
|
5P01CA018029-36
|
$5,431,018
|
$5,431,018
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
TRAINING IN CANCER BIOLOGY AND TRANSPLANTATION
|
5T32CA009515-27
|
$615,630
|
$615,630
|
APPELBAUM, FREDERICK
|
UNIVERSITY OF WASHINGTON
|
|
Cytogenetic Studies of B-cell Chronic Lymphocytic Leukemia (B-CLL)
|
ZIA SC 010282
|
$121,487
|
$24,297
|
Arthur, Diane
|
CCR (NCI)
|
|
Clinical Cancer Cytogenetics
|
ZID BC 010694
|
$425,206
|
$212,602
|
Arthur, Diane
|
CCR (NCI)
|
|
Bone Marrow Stem Cells Participation in Solid Organ Cancers Carcinogenesis
|
ZIA BC 011004
|
$255,308
|
$255,308
|
Avital, Itzhak
|
CCR (NCI)
|
|
Southwest Oncology Group Treatment Grant
|
3U10CA032102-32S1
|
$665,444
|
$6,654
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Southwest Oncology Group Treatment Grant
|
5U10CA032102-32
|
$8,893,886
|
$88,939
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs
|
5U10CA037429-27
|
$2,878,195
|
$28,782
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Growth Control in Multiple Myeloma
|
5P01CA055819-17
|
$3,653,305
|
$1,461,322
|
BARLOGIE, BART
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
|
The University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer
|
5P50CA083639-12
|
$2,117,925
|
$127,076
|
BAST, ROBERT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S5
|
$11,164,583
|
$111,646
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S6
|
$75,000
|
$750
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Pediaric Oncology Research Training Program
|
5T32CA009351-33
|
$177,227
|
$70,891
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Developing Immunoablative Regimens for the Engraftment of Allogeneic HSCT
|
ZIA BC 010698
|
$55,940
|
$39,158
|
Bishop, Michael
|
CCR (NCI)
|
|
Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
|
ZIA BC 011239
|
$55,940
|
$55,940
|
Bishop, Michael
|
CCR (NCI)
|
|
Optimizing the Graft-Versus-Tumor Effect in Allogeneic HSCT
|
ZIA SC 010365
|
$74,587
|
$74,587
|
Bishop, Michael
|
CCR (NCI)
|
|
To establish the BC Cancer Agency - Vancouver Centre as a major SWOG centre
|
5U10CA142559-02
|
$188,304
|
$1,883
|
BLANKE, CHARLES
|
BRITISH COLUMBIA CANCER AGENCY
|
|
Allogeneic stem cell transplant with grafts depleted of naive T cells for leukemi
|
1K23CA154532-01
|
$169,590
|
$169,590
|
Bleakley, Marie
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
The role of myeloid suppressor cells in tumor-specific tolerance
|
5R01CA124996-05
|
$302,252
|
$99,743
|
BORRELLO, IVAN
|
JOHNS HOPKINS UNIVERSITY
|
|
Hematopoietic Lineage-restricted Minor Histocompatibility Antigens as GVL Targets
|
5R01CA118880-05
|
$228,126
|
$228,126
|
BRICKNER, ANTHONY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
The Therapy of CML
|
5P01CA049639-21
|
$3,438,273
|
$446,975
|
CHAMPLIN, RICHARD
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Novel Approaches to Stem Cell Transplantation
|
5P01CA047741-18
|
$1,781,177
|
$1,781,177
|
Chao, Nelson
|
DUKE UNIVERSITY
|
|
Determinants of late cardiovascular morbidity among survivors of hematopoietic ce
|
1K07CA151775-01A1
|
$151,059
|
$151,059
|
Chow, Eric
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Genetic Therapy for Fanconi Anemia
|
1R01CA155294-01
|
$319,550
|
$159,775
|
CLAPP, DAVID
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Mechanisms of Symptoms of Multiple Myeloma and Its Therapy
|
5P01CA124787-04
|
$1,979,082
|
$197,908
|
CLEELAND, CHARLES
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Adoptive immunotherapy after umbilical cord blood transplant
|
5R01CA124782-05
|
$283,822
|
$283,822
|
COOPER, LAURENCE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
T-cell Therapy for B-lineage Acute Lymphoblastic Leukemia
|
5R01CA141303-02
|
$318,015
|
$318,015
|
COOPER, LAURENCE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-37S1
|
$116,988
|
$12,869
|
Corey, Lawrence
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-37S2
|
$704,000
|
$77,440
|
Corey, Lawrence
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-37S3
|
$211,800
|
$23,298
|
Corey, Lawrence
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-37S4
|
$75,000
|
$8,250
|
Corey, Lawrence
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-37S5
|
$139,269
|
$15,320
|
Corey, Lawrence
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
5P30CA015704-37
|
$10,429,029
|
$1,147,193
|
Corey, Lawrence
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Biobehavioral Mechanisms Facilitating Recovery From Stem Cell Transplantation
|
1K07CA136966-01A2
|
$148,785
|
$37,196
|
Costanzo, Erin
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Predictors of Optimal Immune Reconstitution in Stem Cell Transplant Patients
|
5R21CA133343-02
|
$156,650
|
$78,325
|
Costanzo, Erin
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Dermatology Consultation Service
|
ZID BC 011317
|
$863,668
|
$215,917
|
Cowen, Edward
|
CCR (NCI)
|
|
SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER
|
5U10CA038926-26
|
$4,603,957
|
$46,040
|
CROWLEY, JOHN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer following bone-marrow transplantation
|
ZIA CP010131-04020
|
$135,580
|
$135,579
|
Curtis, Rochelle
|
DCEG (NCI)
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-13S1
|
$120,015
|
$2,400
|
Dalton, William
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-13S2
|
$75,000
|
$1,500
|
Dalton, William
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
5P30CA076292-13
|
$2,657,144
|
$53,143
|
Dalton, William
|
H. LEE MOFFITT CANCER CTR & RES INST
|
Total relevant funding to Bone Marrow Transplantation for this search: $59,761,972
|